NCT03304041 is a NA clinical trial of low-FODMAPs diet in Irritable Bowel Syndrome, sponsored by Sir Run Run Shaw Hospital.

Who is sponsoring NCT03304041?

NCT03304041 is sponsored by Sir Run Run Shaw Hospital.

What drugs are being tested in NCT03304041?

Interventions in NCT03304041: low-FODMAPs diet, Traditional dietary advice.

What condition does NCT03304041 study?

NCT03304041 studies Irritable Bowel Syndrome, Diet Modification.

Is NCT03304041 still recruiting?

NCT03304041 is currently completed. Last updated 12 September 2019.

Last reviewed 2019-09-12 · How we verify

NCT03304041

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Low-FODMAPs Dietary Therapy for Irritable Bowel Syndrome in China

Completed NA Last updated 12 September 2019

What this trial tests

NA trial testing low-FODMAPs diet in Irritable Bowel Syndrome in 108 participants. Completed in 31 May 2019.

Timeline

10 October 2017

Primary endpoint
31 May 2018

31 May 2019

Quick facts

Lead sponsor	Sir Run Run Shaw Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	108
Start date	10 October 2017
Primary completion	31 May 2018
Estimated completion	31 May 2019
Sites	1 location across China

Drugs / interventions tested

low-FODMAPs diet
Traditional dietary advice

Conditions studied

Irritable Bowel Syndrome — all drugs for Irritable Bowel Syndrome →
Diet Modification — all drugs for Diet Modification →

Sponsor

Sir Run Run Shaw Hospital

Who can join

Adults 18 to 65, any sex, with Irritable Bowel Syndrome or Diet Modification. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim of our study is to carry out a randomized trial to evaluate the efficacy of low-FODMAPs dietary therapy compared to conventional therapy for IBS patients recruited from tertiary hospitals in China. Secondary aims of this research include an analysis of clinical, physiological and microbiological factors that may predict IBS patient response to this dietary intervention.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Gut liver brain axis in diseases: the implications for therapeutic interventions.
Yan M, Man S, Sun B, Ma L, et al · · 2023 · cited 165× · PMID 38057297 · DOI 10.1038/s41392-023-01673-4
Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet compared with traditional dietary advice for diarrhea-predominant irritable bowel syndrome: a parallel-group, randomized controlled trial with analysis of clinical and microbiological factors assoc
Zhang Y, Feng L, Wang X, Fox M, et al · · 2021 · cited 71× · PMID 33740048 · DOI 10.1093/ajcn/nqab005

Verify or expand the search:

Other recruiting trials for Irritable Bowel Syndrome

Currently open trials in the same condition.

NCT07235228 — Effects of Vivatlac Synbiotic on Gut Micribiota of IBS Patients · NA · recruiting
NCT07421011 — Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 · Phase 1 · recruiting
NCT07360938 — Drug Interaction Potential of Pro-Inflammatory Conditions · recruiting
NCT06788444 — Efficacy of Esketamine for Patients With Irritable Bowel Syndrome · NA · recruiting
NCT07484412 — Efficacy and Safety of Encapsulated Bifidobacterium Longum BBH016 in Subjects With Lower Gastrointestinal Symptoms · NA · active not recruiting

Other Sir Run Run Shaw Hospital trials

Trials by the same sponsor.

NCT07453940 — Left Atrial Appendage Closure With Versus Without Pulsed Field Ablation in Atrial Fibrillation Patients With Mild Sympto · NA · recruiting
NCT07508943 — Decision-making and Optimization of Ventilatory Support for AECOPD Patients · not yet recruiting
NCT07514533 — The Efficacy and Safety of Pucotenlimab (PD-1) Combined With Becotatugvedotin (EGFR-ADC) in Advanced Cholangiocarcinoma · Phase 2 · not yet recruiting
NCT07350590 — Comparison Between Robotic and Laparoscopic Right Hemicolectomy · terminated
NCT07457073 — AI-Powered Sound Analysis for COPD Screening · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03304041 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sir Run Run Shaw Hospital
Last refreshed: 12 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03304041.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing